Literature DB >> 15696248

Is neck dilatation after endovascular aneurysm repair graft dependent? Results of 4 US Phase II trials.

Ellen D Dillavou1, Satish Muluk, Michel S Makaroun.   

Abstract

Long-term success of endovascular aneurysm repair (EVAR) relies on a stable proximal neck. The authors' goal was to determine whether neck dilatation after EVAR varies among 4 different endografts and whether it is related to complications of the proximal neck. Core laboratory data from 4 phase II trials of aortic endografts were analyzed for neck diameter changes over time. Patients who had at least 24 months' follow-up were included in the analysis. Neck measurement methodology varied among the 3 core labs used. Values are reported within the parameters used by each lab. Short-axis neck diameter close to 5 mm below the renal arteries, when available, was used for longitudinal comparisons. Dilation was defined as an enlargement of 3 mm or more from the first postoperative scan to the last available follow-up for each patient. Graft migration and late proximal endoleaks were determined by the individual core labs. A limited number of Lifepath grafts had most recent follow-up measurements performed by the authors. Results were compared by using Student's t test, chi-square analysis, and the Pearson correlation coefficient. Postoperative measurements from 729 EVAR patients were examined. Follow-up ranged from 24 to 60 months for 229 Ancure (Guidant) and 258 AneuRx (Medtronic) patients, and from 24 to 36 months for 211 Excluder (Gore) and 31 first-generation Lifepath (Edwards) patients. Neck dilation was noted in 124 patients (17.0%) and did not differ significantly among graft types. The incidences of late proximal endoleaks were similar among graft types, but rates of migration differed (p=0.01). Dilation was associated with migration in Ancure (p=0.03) and Excluder (p=0.02) grafts. Late proximal endoleaks were seen in 4.1% of patients with and in 0.7% of patients without dilation (p=0.001). Patients with initial neck diameter >25 mm had significantly less dilatation than those with smaller necks (p<0.001). The incidence of neck dilation approached 20% in all EVAR patients after 24 months and was not significantly different among graft types. Neck dilation of 3 mm or more appears to be one risk factor for migration and late proximal endoleak.

Entities:  

Mesh:

Year:  2005        PMID: 15696248     DOI: 10.1177/153857440503900105

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  5 in total

1.  Long-term follow-up of neck expansion after endovascular aortic aneurysm repair.

Authors:  Thomas S Monahan; Timothy A M Chuter; Linda M Reilly; Joseph H Rapp; Jade S Hiramoto
Journal:  J Vasc Surg       Date:  2010-08       Impact factor: 4.268

Review 2.  Proximal Aortic Neck Progression: Before and After Abdominal Aortic Aneurysm Treatment.

Authors:  Konstantinos A Filis; George Galyfos; Fragiska Sigala; Konstantinos Tsioufis; Ioannis Tsagos; Georgios Karantzikos; Christos Bakoyiannis; George Zografos
Journal:  Front Surg       Date:  2017-05-04

3.  Evolution of the Proximal Sealing Rings of the Anaconda Stent-Graft After Endovascular Aneurysm Repair.

Authors:  Maaike A Koenrades; Almar Klein; Anne M Leferink; Cornelis H Slump; Robert H Geelkerken
Journal:  J Endovasc Ther       Date:  2018-04-30       Impact factor: 3.487

4.  Geometric Remodeling of the Perirenal Aortic Neck at and Adjacent to the Double Sealing Ring of the Anaconda Stent-Graft After Endovascular Aneurysm Repair.

Authors:  Maaike A Koenrades; Marianne R F Bosscher; Jouke T Ubbink; Cornelis H Slump; Robert H Geelkerken
Journal:  J Endovasc Ther       Date:  2019-12       Impact factor: 3.487

5.  Funnel technique for wide infrarenal aneurysm neck with Lifetech Ankura™ Stent Graft System.

Authors:  Hakkı Zafer İşcan; Ertekin Utku Ünal; Naim Boran Tümer; Bekir Boğaçhan Akkaya; Göktan Aşkın; Sefa Sağlam; Sabir Hasanzade; Hayrettin Levent Mavioğlu
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-07-26       Impact factor: 0.332

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.